多发性硬化中促炎性c-Met+ CD4 T细胞
研究比较34例未治疗MS患者与13例非炎性神经疾病患者配对血和脑脊液中c-Met+ CD4 T细胞。MS患者血和CSF中c-Met+记忆CD4 T细胞比例更高,且表达更多促炎因子和整合素,迁移能力受抗整合素抗体抑制。提示c-Met可作为MS促炎迁移性CD4 T细胞的免疫标志物。
要点
- MS患者血和CSF中c-Met+记忆CD4 T细胞比例显著高于NIND。
- c-Met+ CD4 T细胞高表达GM-CSF、IL-17、IFN-γ及IL-17+IFN-γ+双阳性。
- 抗VLA-4和抗LFA-1抗体主要抑制c-Met+ CD4 T细胞迁移。
核心结论
- c-Met是MS患者外周和中枢神经系统中高促炎性和迁移性CD4 T细胞的免疫标志物。
研究设计与样本
- 研究纳入34例未治疗MS患者(年龄28-44岁)和13例非炎性神经疾病患者(年龄34-51岁),在诊断检查时配对采集血和脑脊液。
- 采用流式细胞术和bulk RNA测序进行CD4 T细胞表型和功能表征,并研究黏附和跨迁移能力。
主要发现
- MS患者血中c-Met+记忆CD4 T细胞中位数为1.98%,CSF中为5.88%,高于NIND患者的0.37%和0.68%(p < 0.0001)。
- 离体c-Met+ CD4 T细胞较c-Met- CD4 T细胞表达更高水平的GM-CSF、IL-17、IFN-γ及IL-17+IFN-γ+双阳性。
- c-Met+ CD4 T细胞较c-Met- CD4 T细胞表达更高水平的整合素Itgα4β1(VLA-4)和ItgαLβ2(LFA-1)。
- 抗Itgα4(natalizumab)和抗ItgαLβ2(odulimomab)抑制CD4 T细胞跨迁移,且主要抑制表达c-Met的CD4 T细胞。
临床怎么用
- c-Met+ CD4 T细胞可作为MS中促炎和迁移性T细胞的潜在生物标志物。
- 靶向VLA-4和LFA-1的治疗可能优先影响c-Met+ CD4 T细胞。
局限性
- 样本量较小(34例MS和13例NIND),需更大队列验证。
- 研究为横断面设计,无法确定c-Met+ CD4 T细胞在MS发病中的因果作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hepatocyte growth factor (HGF) binds exclusively the c-Met surface receptor, and the HGF/c-Met axis regulates T cell function in autoimmune diseases. We analyzed c-Met expression on human CD4 T cells in the blood and cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) versus non-inflammatory neurological disease (NIND), to better understand the role of CD4 T cells in MS. METHODS: We recruited 34 untreated MS patients (age 28-44 years) and 13 NIND (age 34-51 years) who underwent paired blood and CSF sampling at the time of diagnosis work-up. Phenotypic and functional CD4 T cells characterization was determined by flow cytometry and bulk RNA sequencing. Adhesion and transmigration capacities were studied to further characterize the function of c-Met+ CD4 T cells. RESULTS: c-Met+ memory CD4 T cells were detected at higher levels in both blood (median of 1.98%) and CSF (5.88%) in MS compared to NIND (0.37% and 0.68%, respectively) (p < 0.0001). Ex vivo c-Met+ CD4 T cells exhibited higher levels of GM-CSF, interleukin (IL)-17, interferon (IFN)- γ , and double positive IL-17+IFN- γ + expression, compared with c-Met- CD4 T cells. c-Met+ CD4 T cells expressed increased levels of integrins-Itgα4β1 (VLA-4) and ItgαLβ2 (LFA-1)-compared with c-Met- CD4 T cells. Anti-Itgα4 (natalizumab) and anti-ItgαLβ2 (odulimomab) inhibited CD4 T cell transmigration with predominant inhibition of CD4 T cells expressing c-Met. INTERPRETATION: These results emphasize c-Met as an immune marker of highly pro-inflammatory and migratory CD4 T lymphocytes in both the periphery and central nervous system of MS patients. ANN NEUROL 2026;99:261-273.
引用
- Breville G, Benkhoucha M, Rezk A, et al. Pro-Inflammatory c-Met+ CD4 T Cells in Multiple Sclerosis. Ann Neurol. 2025. PMID: 41002109. doi:10.1002/ana.78035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。